The treatment of extensive limb soft tissue sarcoma by isolation perfusion with high dose r-. Tumor necrosis factor alpha combined with melphalan

European Journal of Cancer ◽

10.1016/0959-8049(93)90851-6 ◽

1993 ◽

Vol 29 ◽

pp. S47 ◽

Author(s):

D. Lev ◽

M. Inbar ◽

P. Sorkin ◽

S. Chaitchik ◽

J.M. Klausner

Keyword(s):

Soft Tissue ◽

Tumor Necrosis Factor ◽

Soft Tissue Sarcoma ◽

Tumor Necrosis Factor Alpha ◽

Tumor Necrosis ◽

High Dose ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial.

Journal of Clinical Oncology ◽

10.1200/jco.1997.15.5.2174 ◽

1997 ◽

Vol 15 (5) ◽

pp. 2174-2175 ◽

Author(s):

T Brodowicz ◽

R Kotz ◽

C Wiltschke ◽

C C Zielinski ◽

P Ritschl

Keyword(s):

Soft Tissue ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Soft Tissue Sarcomas ◽

Multicenter Trial ◽

High Dose ◽

Necrosis Factor Alpha ◽

Limb Perfusion ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Isolated limb perfusion (I.L.P.) with high dose melphalan and/or TNFα (tumor necrosis factor alpha) in patients with non resoccable sacroma or metastatic intransit melanoma. Nursing implications

European Journal of Cancer ◽

10.1016/s0959-8049(01)81975-4 ◽

2001 ◽

Vol 37 ◽

pp. S413

Author(s):

N. Belin ◽

Laurence Nicouleau ◽

Philippe Israël ◽

Sylvie Bonvalot

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis Factor Alpha ◽

Tumor Necrosis ◽

Isolated Limb Perfusion ◽

High Dose ◽

Necrosis Factor Alpha ◽

Limb Perfusion ◽

Factor Alpha ◽

High Dose Melphalan ◽

Necrosis Factor

Download Full-text

High-dose tumor necrosis factor-alpha leads to the systemic inflammatory response syndrome

The American Journal of Medicine ◽

10.1016/s0002-9343(98)00265-4 ◽

1998 ◽

Vol 105 (4) ◽

pp. 346-347 ◽

Author(s):

Karl J Oldhafer ◽

Hauke Lang ◽

Ernst R Kuse ◽

Michael U Martin

Keyword(s):

Tumor Necrosis Factor ◽

Systemic Inflammatory Response Syndrome ◽

Inflammatory Response ◽

Tumor Necrosis Factor Alpha ◽

Tumor Necrosis ◽

Systemic Inflammatory Response ◽

High Dose ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Complications of combined radiotherapy and isolated limb perfusion with tumor necrosis factor alpha ± interferon gamma and melphalan in patients with irresectable soft tissue tumors

Journal of Surgical Oncology ◽

10.1002/(sici)1096-9098(199706)65:2<88::aid-jso4>3.0.co;2-j ◽

1997 ◽

Vol 65 (2) ◽

pp. 88-94 ◽

Author(s):

Bart C. Vrouenraets ◽

Ronald B. Keus ◽

Omgo E. Nieweg ◽

Bin B. Kroon

Keyword(s):

Soft Tissue ◽

Tumor Necrosis Factor ◽

Tumor Necrosis Factor Alpha ◽

Interferon Gamma ◽

Tumor Necrosis ◽

Soft Tissue Tumors ◽

Necrosis Factor Alpha ◽

Limb Perfusion ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Effect of High-Dose Medroxyprogesterone Acetate on Tumor Necrosis Factor-Alpha Release in Patients with Chemotherapy-Induced Neutropenia

Journal of Chemotherapy ◽

10.1179/joc.1997.9.5.377 ◽

1997 ◽

Vol 9 (5) ◽

pp. 377-381

Author(s):

F. Aydin ◽

S. Ulusoy ◽

E. Ovali ◽

M. Sonmez

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis Factor Alpha ◽

Medroxyprogesterone Acetate ◽

Tumor Necrosis ◽

High Dose ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Chemotherapy Induced Neutropenia ◽

Necrosis Factor

Download Full-text

High-dose tumor necrosis factor alpha produces an impairment of hamster diaphragm contractility. Attenuation with a prostaglandin inhibitor.

American Journal of Respiratory and Critical Care Medicine ◽

10.1164/ajrccm.153.5.8630610 ◽

1996 ◽

Vol 153 (5) ◽

pp. 1611-1615 ◽

Author(s):

P Wilcox ◽

C Milliken ◽

B Bressler

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis Factor Alpha ◽

Tumor Necrosis ◽

High Dose ◽

Necrosis Factor Alpha ◽

Prostaglandin Inhibitor ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Isolated Hyperthermic Liver Perfusion with High Dose Tumor Necrosis Factor Alpha in Pigs: An Experimental Study in Preparation of Clinical Use

European Surgical Research ◽

10.1159/000008734 ◽

2000 ◽

Vol 32 (1) ◽

pp. 1-10 ◽

Author(s):

H. Lang ◽

A. Thyen ◽

S. Nadalin ◽

M. Frerker ◽

L. Moreno ◽

...

Keyword(s):

Experimental Study ◽

Tumor Necrosis Factor ◽

Tumor Necrosis Factor Alpha ◽

Tumor Necrosis ◽

Liver Perfusion ◽

High Dose ◽

Clinical Use ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

620 The role of tumor necrosis factor alpha in preconditioning by hyperoxia

European Journal of Heart Failure Supplements ◽

10.1016/s1567-4215(03)90411-5 ◽

2003 ◽

Vol 2 (1) ◽

pp. 135

Author(s):

F LABRUTO ◽

J YANG ◽

J VAAGE ◽

G VALEN

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis Factor Alpha ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

629 N-terminal pro brain natriuretic peptide and tumor necrosis factor alpha and outcome in patients with heart failure with reduced vs. preserved systolic function

European Journal of Heart Failure Supplements ◽

10.1016/s1567-4215(06)80426-1 ◽

2006 ◽

Vol 5 (1) ◽

pp. 147-148

Author(s):

N STANCHEVA ◽

S TISHEVA ◽

S KURKCHIEV ◽

A GOUDEV

Keyword(s):

Heart Failure ◽

Tumor Necrosis Factor ◽

Brain Natriuretic Peptide ◽

Tumor Necrosis Factor Alpha ◽

Tumor Necrosis ◽

Systolic Function ◽

Necrosis Factor Alpha ◽

Patients With Heart Failure ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

563 Interleukin-6 and tumor necrosis factor alpha in relation to myocardial infarct size and collagen formation

European Journal of Heart Failure Supplements ◽

10.1016/s1567-4215(03)90368-7 ◽

2003 ◽

Vol 2 (1) ◽

pp. 121

Author(s):

M PUHAKKA ◽

J MAGGA ◽

S HIETAKORPI ◽

I PENTTILA ◽

P UUSIMAA ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Infarct Size ◽

Tumor Necrosis Factor Alpha ◽

Tumor Necrosis ◽

Myocardial Infarct ◽

Myocardial Infarct Size ◽

Necrosis Factor Alpha ◽

Collagen Formation ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text